Latest Chemical Manufacturing News

Page 1 of 2
DGL Group has acknowledged a $40.2 million statutory loss for FY26, as higher input costs, weak battery supply and underused facilities eroded margins. Management says earnings improved materially in the first quarter of FY27, but has provided no figures to show how much of the recovery is sustainable.
Victor Sage
Victor Sage
10 Nov 2026
Noxopharm has secured a $1.5 million placement and agreed to convert $3.78 million of shareholder notes as it prepares to test SOF-SKN in cutaneous lupus patients. The funding eases an immediate cash constraint, but the package also brings substantial dilution and remains partly subject to shareholder approval.
Ada Torres
Ada Torres
2 Nov 2026
Nanollose has narrowed its microbial cellulose scale-up plan to one company-controlled Western Australian pilot facility, with all Stage 1 equipment ordered and paid for. The progress comes with a clear funding constraint: the ASX-listed biomaterials developer ended September with $758,000 in cash, equivalent to 1.41 quarters of funding at its current operating burn.
Victor Sage
Victor Sage
30 Oct 2026
Noxopharm says the FDA has supported its proposed Phase II design and chemical manufacturing strategy for SOF-SKN, its topical treatment candidate for cutaneous lupus erythematosus. The feedback improves regulatory clarity, but the trial remains targeted for the first half of calendar 2028 and is subject to further studies and regulatory requirements.
Ada Torres
Ada Torres
8 Oct 2026
Foresta Group Holdings has received allowance from the USPTO for its US patent application covering its proprietary rosin and terpene production process, expected to protect its technology until at least 2041.
Victor Sage
Victor Sage
6 July 2026
DGL Group Limited has agreed to sell two chlor-alkali manufacturing plants for $2.5 million, well below their carrying value, reflecting a $5.3 million impairment charge. The sale aligns with the company’s strategic focus on core operations and is not expected to materially affect ongoing activities.
Victor Sage
Victor Sage
9 Apr 2026
Japan Fluorite Corporation has completed its second $5 million tranche investment in the Speewah Fluorite Project, advancing the feasibility study for Australia's first acidgrade fluorspar operation.
Maxwell Dee
Maxwell Dee
1 Apr 2026
International Graphite Limited (IG6) has partnered with Italian chemical giant ALKEEMIA to establish a cutting-edge graphite processing facility in Italy, targeting production by late 2027. This joint venture aims to secure Europe's graphite supply chain amid rising demand and regulatory pressures.
Maxwell Dee
Maxwell Dee
26 Mar 2026
Tivan Limited’s joint venture partners have approved the Feasibility Study for the Speewah Fluorite Project and committed a $5 million equity injection to advance development.
Maxwell Dee
Maxwell Dee
20 Mar 2026
Tivan Limited has submitted a confidential draft Feasibility Study for its Speewah Fluorite Project to key partners, marking a significant step towards project finalisation and potential production.
Maxwell Dee
Maxwell Dee
23 Feb 2026
Tivan Limited has locked in $11.3 million in initial funding from ETFS Capital, marking a key step forward for the Speewah Fluorite Project in Western Australia. This strategic partnership accelerates development towards a Final Investment Decision expected in 2026.
Maxwell Dee
Maxwell Dee
7 Jan 2026
Liontown Limited has inked a binding two-year offtake agreement with Canmax Technologies for 150,000 wet metric tonnes of spodumene concentrate annually in 2027 and 2028, reinforcing its foothold in the lithium supply chain.
Maxwell Dee
Maxwell Dee
9 Dec 2025

Browse the archive

Full archive